265
Views
3
CrossRef citations to date
0
Altmetric
Commentary

The importance of immunoparesis in multiple myeloma

ORCID Icon
Pages 769-770 | Received 04 Dec 2020, Accepted 05 Dec 2020, Published online: 25 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Morie Gertz. (2022) Smoldering multiple myeloma: Reviewing the rationale for intervention. Leukemia & Lymphoma 63:9, pages 2033-2040.
Read now

Articles from other publishers (2)

Carol Gung, Regina McGuire, Mercy George, Abdullateef Abdulkareem, Katherine A. Belden, Pierluigi Porcu, Ubaldo Martinez-Outschoorn, Adam F. Binder, Inna Chervenova & Onder Alpdogan. (2022) Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination. Frontiers in Oncology 12.
Crossref
Marcella Kaddoura, Moritz Binder, David Dingli, Francis K. Buadi, Martha Q. Lacy, Morie A. Gertz, Angela Dispenzieri, Prashant Kapoor, Lisa Hwa, Amie Fonder, Miriam Hobbs, Suzanne Hayman, Nelson Leung, Ronald S. Go, Yi Lin, Wilson Gonsalves, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, Vincent Rajkumar & Shaji Kumar. (2022) Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome. American Journal of Hematology 97:3, pages 267-273.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.